See also this year's filing and all EDGAR filings for this company.
PDF Report 0001412486_2018_Cocrystal_Pharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001412486')"} |
Graph
Absolute values for 0001412486, Cocrystal Pharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 2,176,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 65,195,000 |
2 | PropertyPlantAndEquipmentNet | 119,000 |
3 | remainder_Assets | 53,936,000 |
4 | LiabilitiesCurrent | 1,406,000 |
5 | LiabilitiesNoncurrent | 14,620,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 2,440,000 |
9 | ResearchAndDevelopmentExpense | 5,822,000 |
10 | remainder_Expenses | -6,880,000 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 769,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 121,426,000 |
1 | Liabilities | 16,026,000 |
2 | Expenses | 1,382,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 105,400,000 |
5 | NetIncome | -613,000 |
6 | ComprehensiveNetIncome | -613,000 |
7 | BaseVar | 69,801,500 |
8 | EconomicCapitalRatio | 2.63 |